HRMY's three largest insider shareholders as of August 29, 2026 are Fund Trust Ii Marshman (TenPercentOwner, 6.05Mn shares), Fund Trust Ii Marshman (TenPercentOwner, 6.05Mn shares), Andreas Wicki (Director, 4.40Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Fund Trust Ii Marshman | TenPercentOwner | 6,051,120 | 0 | 6,051,120 | 45.4% | 05 Nov, 2024 |
| 2 | Andreas Wicki | Director | 0 | 4,402,580 | 4,402,580 | 33.0% | 14 Dec, 2022 |
| 3 | Jack Nielsen | Director | 0 | 2,571,024 | 2,571,024 | 19.3% | 16 Dec, 2022 |
| 4 | Jeffrey S Aronin | Director | 251,922 | 0 | 251,922 | 1.9% | 16 Dec, 2021 |
| 5 | Sandip Kapadia | Chief Financial Officer | 24,521 | 0 | 24,521 | 0.2% | 28 Jan, 2026 |
| 6 | Kumar Budur | Chief Medical Officer | 24,115 | 0 | 24,115 | 0.2% | 18 May, 2026 |
| 7 | Jeffrey M. Dayno | President, Ceo | 7,346 | 0 | 7,346 | 0.1% | 26 Jan, 2026 |
| 8 | Adam H. Zaeske | Chief Commercial Officer | 4,327 | 0 | 4,327 | 0.0% | 09 Apr, 2026 |
| 9 | Andrew Serafin | Chief Strategy Officer | 1,474 | 0 | 1,474 | 0.0% | 26 Jan, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 Apr, 2026 | Glenn Reicin | Chief Financial Officer | Acquired A | 164,309 | $0.00 | $0 | 164,309 | Direct |
| 14 May, 2026 | Gary Sender | Director | Acquired A | 21,872 | $0.00 | $0 | 21,872 | Direct |
| 14 May, 2026 | Linda M Szyper | Director | Acquired A | 21,872 | $0.00 | $0 | 21,872 | Direct |
| 14 May, 2026 | Geno J Germano | Director | Acquired A | 21,231 | $0.00 | $0 | 21,231 | Direct |
| 01 May, 2026 | Kumar Budur | Chief Medical Officer | Acquired M | 18,750 | $0.00 | $0 | 32,997 | Direct |
| 14 May, 2026 | Juan A. Sabater | Director | Acquired A | 21,872 | $0.00 | $0 | 21,872 | Direct |
| 01 May, 2026 | Kumar Budur | Chief Medical Officer | Disposed F | 8,882 | $31.83 | $282.71K | 24,115 | Direct |
| 01 May, 2026 | Kumar Budur | Chief Medical Officer | Disposed M | 18,750 | $0.00 | $0 | 37,500 | Direct |
| 07 Apr, 2026 | Adam H. Zaeske | Chief Commercial Officer | Acquired M | 7,500 | $0.00 | $0 | 7,500 | Direct |
| 07 Apr, 2026 | Adam H. Zaeske | Chief Commercial Officer | Disposed F | 3,173 | $27.62 | $87.64K | 4,327 | Direct |
| 07 Apr, 2026 | Adam H. Zaeske | Chief Commercial Officer | Disposed M | 7,500 | $0.00 | $0 | 7,500 | Direct |
| 02 Apr, 2026 | Troy A. Ignelzi | Director | Acquired A | 17,710 | $0.00 | $0 | 17,710 | Direct |
| 02 Apr, 2026 | Peter Anastasiou | Chief Operating Officer | Acquired A | 212,241 | $0.00 | $0 | 212,241 | Direct |
| 26 Jan, 2026 | Sandip Kapadia | Chief Financial Officer | Disposed S | 3,746 | $37.15 | $139.17K | 24,521 | Direct |
| 24 Jan, 2026 | Andrew Serafin | Chief Strategy Officer | Acquired M | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 24 Jan, 2026 | Kumar Budur | Chief Medical Officer | Acquired M | 2,188 | $0.00 | $0 | 2,188 | Direct |
| 24 Jan, 2026 | Andrew Serafin | Chief Strategy Officer | Acquired M | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 24 Jan, 2026 | Andrew Serafin | Chief Strategy Officer | Acquired M | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 24 Jan, 2026 | Andrew Serafin | Chief Strategy Officer | Acquired M | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 24 Jan, 2026 | Jeffrey M. Dayno | President, Ceo | Acquired M | 10,500 | $0.00 | $0 | 10,500 | Direct |